SA213 - Regulation of Cannabis Derived Products in Veterinary Medicine

Wednesday, February 22, 2023

2:00 PM – 2:50 PM

Location: Mandalay Bay J, Level 2

Earn 1 CE Hours

Presenter(s)

Lara Maxwell, DVM, DACVCP, PhD (she/her/hers)

Professor of Pharmacology
Oklahoma State University
Stillwater, OK, United States

Moderator(s)

Doug Yanik, DVM

Scientific Services Veterinarian
Doug Yanik Consulting
Cary, NC, United States

Recently, many states have changed their regulation of cannabis and now allow medical and/or recreational use of phytocannabinoids in people. These state changes are at odds with the continuing Federal status of marijuana as a Schedule I drug and do not apply to veterinary patients. Although CBD is widely available, its regulatory status remains unclear, and the veterinary role in dispensing or even discussing non-approved CBD products is fraught and varies by state, as will be discussed.

Learning Objectives:

Upon completion, participant will be able to relate phytocannabinoids to the functions of the endocannabinoid system.
Upon completion, participant will be able to reconcile the national and state approaches to cannabis regulation.
Upon completion, participant will be able to interpret whether state medical cannabis laws apply to veterinary medicine.
Upon completion, participant will be able to characterize the regulatory status of cannabidiol (CBD) in veterinary medicine.
Upon completion, participant will be able to identify whether the Animal Medicinal Drug Use Clarification Act (AMDUCA) applies to cannabis and its derivatives.